H19 Rises in Gastric Cancer and Exerts a Tumor-Promoting Function via miR-138/E2F2 Axis
Jingrong Yu,Cheng Fang,Ziyue Zhang,Guifang Zhang,Lihong Shi,Jiayi Qian,Jianping Xiong,JiaYi Qian
DOI: https://doi.org/10.2147/CMAR.S267357
2020-12-21
Cancer Management and Research
Abstract:Jingrong Yu, 1, * Cheng Fang, 2, * Ziyue Zhang, 2 Guifang Zhang, 3 Lihong Shi, 4 Jiayi Qian, 5 Jianping Xiong 6 1 Department of Oncology, The Fourth Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330003, People's Republic of China; 2 Department of Oncology, Nanchang 334 Hospital, Nanchang, Jiangxi Province, People's Republic of China; 3 Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China; 4 Department of Gynecology and Pediatrics, Nanchang 334 Hospital, Nanchang, Jiangxi Province, People's Republic of China; 5 Department of Ultrasound Electrophysiology, Nanchang 334 Hospital, Nanchang, Jiangxi Province, People's Republic of China; 6 Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, People's Republic of China *These authors contributed equally to this work Correspondence: Jianping Xiong Department of Oncology, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Street, Nanchang, Jiangxi Province 330006, People's Republic of China Tel +86-13265847851 Email jpxiong@medmail.com Purpose: The aim of this paper was to investigate H19 expression in gastric cancer (GC) and its effects on the biological behavior of gastric cancer cells (GCCs), and at exploring its potential mechanism. Methods: H19 expression in the patients' tissues and serum was detected, and the correlation of the expression with the patients' pathological data and survival rate was analyzed. Overexpression or inhibitory vectors of H19 , microRNA-138 ( miR-138 ) and E2F2 were constructed and transfected into GCCs to observe their effects on the cells' proliferation, invasion and apoptosis. Results: H19 rose in GC and was higher in GC patients with a tumor size ≥ 5 cm, high stages (III+IV) and lymph node metastasis. High H19 expression was associated with the poorer survival rate of the patients, so serum H19 had a certain diagnostic value for GC. H19 knockdown could inhibit GCCs to proliferate and invade and induce their apoptosis. miR-138 can be used as the target gene of H19 , and E2F2 can be negatively regulated by this miR, so miR-138 knockdown or E2F2 upregulation can weaken GCCs' biological behavior changes that were caused by H19 knockdown. Conclusion: H19 can be used as a biological indicator for diagnosing GC and predicting patients' poor prognosis. Additionally, it promotes GCCs to proliferate and invade through miR-138 / E2F2 axis. Keywords: H19 , miR-138 , E2F2 , gastric cancer
oncology